CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy of investigational products in participants with an Alzheimer's disease-causing mutation by determining if treatment with ...
Phase 2, Phase 3
Pittsburgh, Pennsylvania, United States and 37 other locations
To assess the safety, tolerability, biomarker, cognitive, and clinical efficacy of investigational products in participants with an Alzheimer's...
Phase 2, Phase 3
Pittsburgh, Pennsylvania, United States and 37 other locations
progression of AD, as compared to no stimulation (OFF), by measuring baseline (pre-implantation) to 12-month change in the integrated Alzheimer's...
Pittsburgh, Pennsylvania, United States and 20 other locations
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
Pittsburgh, Pennsylvania, United States and 117 other locations
investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing mutation. Part 1 will determi...
Phase 2, Phase 3
Pittsburgh, Pennsylvania, United States and 34 other locations
This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...
Phase 3
Beaver, Pennsylvania, United States and 275 other locations
Clinical trials
Research sites
Resources
Legal